Suchergebnisse - "Yao, Hang-Ping"

PubPharm (194)

81

Synergistic activities of MET/RON inhibitor BMS-777607 and mTOR inhibitor AZD8055 to polyploid cells derived from pancreatic cancer and cancer stem cells

enthalten in: Molecular cancer therapeutics | 2014

von Zeng, J. | Sharma, S. | Zhou, Y. | +4

82

Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced inflammation in human retinal endothelial cells

enthalten in: International journal of ophthalmology | 2014

von Zhang, H. | Wang, J. | Yao, H.

83

Study of RON mediated invasion of Raji cell line and drug-target effects

enthalten in: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi | 2013

von Zhan, B. | Dong, Y. | Fan, J. | +3

84

Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer

enthalten in: Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences | 2013

von Hong, B. | Qian, Y. | Yao, H.

85

Pathogenesis of RON receptor tyrosine kinase in cancer cells : activation mechanism, functional crosstalk, and signaling addiction

enthalten in: Journal of biomedical research | 2013

von Wang, M. | Zhang, R. | Zhou, Y. | +1

86

MSP-RON signalling in cancer : pathogenesis and therapeutic potential

enthalten in: Nature reviews. Cancer | 2013

von Yao, H. | Zhou, Y. | Zhang, R. | +1

87

Oncogenic variant RON160 expression in breast cancer and its potential as a therapeutic target by small molecule tyrosine kinase inhibitor

enthalten in: Current cancer drug targets | 2013

von Yao, H. | Zhuang, C. | Zhou, Y. | +3

88

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

enthalten in: Current cancer drug targets | 2013

von Yao, H. | Zhuang, C. | Zhou, Y. | +3

89

MSP–RON signalling in cancer: pathogenesis and therapeutic potential

enthalten in: Nature reviews / Cancer | 2013

von Yao, H. | Zhou, Y. | Zhang, R. | +1

90

Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents

enthalten in: Molecular cancer therapeutics | 2013

von Sharma, S. | Zeng, J. | Zhuang, C. | +5